what is a glp 1 agonist Glucagon-like peptide-1 Current Insights, Advantages and Challenges
Description
You start at the lowest dose and gradually increase every four weeks until you reach your target maintenance dose
Theres low-level constant inflammation, immune dysfunction, high levels of hormones like insulin and leptin
Hypokalemia (low potassium) can occur when patients experience significant vomiting or diarrhea while on GLP-1 therapy
Thinking around obesity has shifted over the years
